Showing results (81-90 of 259) with videos related to
Sort By:
Pageof 26
Anti-Cancer Drugs|April 1, 1997
Drug interactions of 5-fluorouracil with either cisplatin or lobaplatin--a new, clinically active platinum analog in established human cancer cell linesA Harstrick, U Vanhoefer, A Heidemann, et al.European Journal of Haematology|January 1, 1996
Prognostic impact of interferon alpha-induced cytogenetic remission in chronic myelogenous leukaemia: long-term follow-upO Kloke, N Niederle, B Opalka, et al.Biochemical Pharmacology|March 21, 1997
Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N- nitrosourea associated with inhibition of multidrug resistance protein (MRP) functionU Vanhoefer, M B Yin, A Harstrick, et al.Experimental Hematology|November 24, 1999
Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myelomaA Fosså, D Brandhorst, J H Myklebust, et al.Anticancer Research|November 1, 1993
Chemosensitisation of alkylating agents by pentoxifylline, O6-benzylguanine and ethacrynic acid in haematological malignanciesM R Müller, J Thomale, C Lensing, et al.Cancer|October 1, 1993
Prognosis and treatment of disseminated uveal melanomaR Kath, J Hayungs, N Bornfeld, et al.European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancerU Klaassen, H Wilke, D Strumberg, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1984
Phase II evaluation of fractionated low and single high dose cisplatin in various tumorsR B Schilcher, M Wessels, N Niederle, et al.Molecular Microbiology|April 20, 2001
MspA provides the main hydrophilic pathway through the cell wall of Mycobacterium smegmatisC Stahl, S Kubetzko, I Kaps, et al.Onkologie|January 1, 1988
[Sequential treatment of progressive metastatic colorectal cancer with 5-fluorouracil/folinic acid, dipyramidole and mitomycin C]F Migeod, D Gerlach, M Kress, et al.Pageof 26